Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
61.24 USD | +1.10% | -1.75% | -36.31% |
05-29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
05-27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.35% | 12.14B | |
-8.41% | 6.33B | |
+42.14% | 2.12B | |
+4.54% | 1.55B | |
+17.74% | 909M | |
+6.61% | 893M | |
-7.88% | 662M | |
-12.95% | 622M | |
-25.21% | 381M |
- Stock Market
- Equities
- CR Stock
- CXT Stock
- News Crane NXT
- Transcript : Crane Co. - Analyst/Investor Day